GBM6-AD lysate protein vaccine ( University of Minnesota)

N/A

Report date: 2024/04/02 20:00:40

Base Information

Drug NameGBM6-AD lysate protein vaccine ( University of Minnesota)
Drug Alias NameGBM6-AD lysate protein vaccineglioma cell lysate vaccine GBM6-ADneoadjuvant glioma vaccine (subcutaneous)GBM6-AD stem cell + poly-ICLC vaccine (subcutaneous, glioma)GBM6-AD
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsDiffuse midline gliomaOligodendrogliomaAstrocytoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of MinnesotaOX2 Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of MinnesotaOX2 Therapeutics
Inactive CompaniesN/A
Active IndicationsDiffuse midline gliomaOligodendrogliomaAstrocytoma +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A